Skip to main content
Clinical Trials/TCTR20210301008
TCTR20210301008
Unknown
Phase 3

A randomised controlled trial comparing cervical medial branch blocks by ultrasound-guided with combined bupivacaine and steroid versus bupivacaine alone for chronic cervical facet joint pain

Mahidol University0 sites54 target enrollmentMarch 1, 2021

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Chronic cervical facet joint pain patients
Sponsor
Mahidol University
Enrollment
54
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2021
End Date
March 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who
  • 1\. 18 years of age
  • 2\. History of chronic, function\-limiting neck pain of at least 3 months duration
  • 3\. Without radicular pain
  • 4\. Without a history of recent cervical surgical procedures within the last 3 months
  • 5\. Diagnosed chronic facet joint pain by cervical median branch block with 2% lidocaine and the pain intensity relief 50 % or more

Exclusion Criteria

  • Patients who
  • 1\. History of adverse reactions to local anesthetic or steroids
  • 2\. Uncontrolled major depression or psychiatric disorders
  • 3\. Acute or uncontrolled medical illness
  • 4\. Women who were pregnant or lactating
  • 5\. Heavy opioid usage defined as oral morphine equivalent more than 300 mg/day

Outcomes

Primary Outcomes

Not specified

Similar Trials